Search clinical trials for: Angiotensin II Type 1 Receptor Blockers

Total 1991 results

Norwegian University of Science and Technology
AstraZeneca

Completed

Prophylactic Treatment of Episodic Cluster Headache

Cluster Headache

Norway
Ain Shams University

Recruiting

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Colorectal Cancer | Chemotherapy | Oral Mucositis | Intestinal Mucositis

Egypt
University of California, San Francisco
Flight Attendant Medical Research Institute

Recruiting

Secondhand Tobacco Smoke and Cardiovascular Disease

Cardiovascular Diseases | Hypertension

United States
Medical University of Lodz

Completed

Effect of Losartan or Eprosartan on Fructose Hyperuricemia (metabolic)

Uric Acid Concentration, Serum, Quantitative Trait Locus 7
Henning Bundgaard

Completed

Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy (INHERIT)

Hypertrophic Cardiomyopathy

Denmark
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function

Myocardial Infarction | Hypertension | Atherosclerosis | Heart Failure, Congestive

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

Myocardial Infarction | Hypertension | Atherosclerosis | Heart Failure, Congestive

United States
Children's Hospital Medical Center, Cincinnati

Recruiting

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Sickle Cell Disease | Diffuse Myocardial Fibrosis

United States
Children's Hospital Medical Center, Cincinnati

Completed

Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

Eosinophilic Esophagitis | Connective Tissue Disorders

United States
The Netherlands Cancer Institute
Roche Pharma AG; AstraZeneca

Completed

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

Breast Cancer

Netherlands
Hannover Medical School
DLR German Aerospace Center

Withdrawn

Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure (ARNI-Sy)

Heart Failure

Germany
Hospital Clínico Universitario de Valladolid

Completed

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study (CandeSpartan)

Migraine | Head Pain

Spain
Brigham and Women's Hospital

Suspended

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Preeclampsia | Pregnancy Induced Hypertension

United States
Stanford University

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Stroke, Acute

United States
Atrial Fibrillation Network
Daiichi Sankyo, Inc.

Completed

Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

Atrial Fibrillation | Arrhythmia | Heart Disease
Sanofi
Bristol-Myers Squibb

Completed

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Myocardial Ischemia | Hypertension

France, Spain, Italy, Belgium, Canada, Germany, Hungary, United States, Netherlands, United Kingdom, Switzerland
RWTH Aachen University
Bayer; Heidelberg University; CTCA

Terminated

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels (ITEM)

Arterial Hypertension | Diabetes Mellitus Type 2 IRC or NIR

Germany
City Hospitals Sunderland NHS Foundation Trust
Takeda

Unknown

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Cerebrovascular Accident | Acute Stroke

United Kingdom
Connolly, Stuart, M.D.
Bristol-Myers Squibb; Sanofi

Unknown

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Hypertension | Atrial Fibrillation

Canada
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Candesartan

Obesity, Morbid

Norway
University of Erlangen-Nürnberg Medical School
Bristol-Myers Squibb

Completed

Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia

Hypercholesterolemia

Germany
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Hypertension

Belgium, Turkey, Hungary, United States, Italy, India, Poland, France, South Africa, Brazil
Novartis

Completed

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Hypertension | Metabolic Syndrome

Germany, Switzerland
Boehringer Ingelheim

Completed

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

Hypertension
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Kagoshima University

Unknown

Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) (KACT)

Hypertension | Obesity

Japan
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Hypertension

Hypertension

Turkey
Odense University Hospital

Unknown

Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

Atrial Fibrillation | Aortic Valve Stenosis | Left Ventricular Hypertrophy

Denmark
Sanofi
Bristol-Myers Squibb

Completed

APROVE : Irbesartan in Hypertension

Hypertension

Algeria
Sanofi
Bristol-Myers Squibb

Completed

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Hypertension

Tunisia
Sharp HealthCare

Completed

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

SARS-CoV Infection

United States
Cristina Avendaño Solá

Recruiting

Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) (EARLY-GENE)

Cardiomyopathy, Dilated

Spain
Abraham Edgar Gracia-Ramos
National Polytechnic Institute, Mexico

Completed

Telmisartan in Respiratory Failure Due to COVID-19 (STAR-COVID)

COVID-19 | Respiratory Insufficiency | Respiratory Distress Syndrome, Adult | Telmisartan

Mexico
Cairo University

Completed

Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions (TRIUMF)

Renal Insufficiency | Heart Failure With Reduced Ejection Fraction

Egypt
Novartis Pharmaceuticals

Completed

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

Hypertension

China
Stanford University
Novartis Pharmaceuticals

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Cerebrovascular Accident

United States
University of Erlangen-Nürnberg Medical School

Completed

Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome

Metabolic Syndrome

Germany
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

Hypertension

China
Providence Health & Services
AstraZeneca

Completed

Angiotensin II Antagonism of TGF-Beta 1

Hypertension | Diabetic Nephropathy

United States
Bassett Healthcare
Goshen Health System; Reid Health

Terminated

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 (COVIDMED)

SARS-CoV-2 Infection

United States
IlDong Pharmaceutical Co Ltd

Unknown

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

Healthy Volunteers

Korea, Republic of
NYU Langone Health

Not yet recruiting

Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

Arthrofibrosis of Knee

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE) (ARCADE)

Ehlers-Danlos Syndrome, Vascular Type

France
Boehringer Ingelheim

Completed

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

Hypertension

Belgium, Canada, Colombia, Czechia, Ecuador, Indonesia, Jordan, Lebanon, Mexico, Turkey, Venezuela, Yemen
University of California, Los Angeles
California HIV/AIDS Research Program

Completed

HIV and Fat Accumulation (MATH)

HIV Infection

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

Hypertension
Novartis

Completed

To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Proteinuria | Microalbuminuria

Egypt
Novartis

Completed

Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

Diastolic Dysfunction, Symptomatic Heart Failure

Switzerland, Germany

Search clinical trials for: Angiotensin II Type 1 Receptor Blockers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations